Dose optimization of intra-operative high dose rate interstitial brachytherapy implants for soft tissue sarcoma

Journal of Cancer Research and Therapeutics

Volumn 5, Issue 4, 2009, Pages 240-246

  Jamema, Swamidas V ^a   Sharma, Pramod K ^a   Sharma, Dayananda ^a   Laskar, Siddhartha ^a   Deshpande, Deepak D ^a   Shrivastava, Shyam K ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

3D image based dosimetry; Graphical optimization; Soft tissue sarcoma implants

Indexed keywords

ARTICLE; BRACHYTHERAPY; CANCER PATIENT; CATHETER; CLINICAL ARTICLE; DOSIMETRY; HUMAN; IMPLANT; INTERSTITIAL RADIATION; INTRAOPERATIVE RADIOTHERAPY; QUANTITATIVE ANALYSIS; SOFT TISSUE SARCOMA; TREATMENT PLANNING;

BRACHYTHERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; SARCOMA; SOFT TISSUE NEOPLASMS;

EID: 77749246405     PISSN: 09731482     EISSN: 19984138     Source Type: Journal    
DOI: 10.4103/0973-1482.59893     Document Type: Article

References (13)

1. Nag S, Shasha D, Janjan N, Petersen I, Zaider M. The American Brachytherapy Society recommendations for brachytherapy of soft tissue sarcomas. Int J Radiat Oncol Biol Phys 2001;49:1033-43.
2. Pisters PW, Harrison LB, Leung DH, Woodruff JM, Casper ES, Brennan MF. Long term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol 1996;14:859-68.
3. Laskar S, Bahl G, Puri A, Agarwal MG, Muckaden M, Patil N, et al. Perioperative interstitial brachytherapy for soft tissue sarcomas: Prognostic factors and long-term results of 155 patients. Ann Surg Oncol 2007;14:560-7.
4. Nath R, Anderson LL, Luxton G, Weaver KA, Williamson JF, Meigooni AS. Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group no 43. Med Phys 1995;22:209-34.
5. Baltas D, Kolotas C, Geramani K, Mould RF, Ioannidis G, Kekchidi M, et al. A conformal index (COIN) to evaluate implant quality and dose specification in brachytherapy. Int J Radiat Oncol Biol Phys 1998;40:515-24.
6. Meertens H, Borger J, Steggerda M, et al. Evaluation and optimization on interstitial brachytherapy dose distributions. In: Mould RF, Battermann, Martinez AA, editors Brachytherapy from radium to optimization. Veenendaal: Nucletron International BV; 1994. p. 300-6.
7. Dose and volume specification for reporting interstitial therapy, ICRU Report 58. Bethesda, USA: ICRU; 1997.
8. Major T, Polgar C, Fodor J, Takacsi-Nagy Z, Mangel L, Nemeth G. Evaluation of geometrically optimized single- and double-plane interstitial high dose rate implants with respect to conformality and homogeneity. Acta Oncol 2003;42:15-21.
9. Major T, Polgar C, Fodor J, Somogyi A, Nemeth G. Conformality and homogeneity of dose distributions in interstitial implants at idealized target volumes: A comparison between the Paris and dose-point optimized systems. Radiother Oncol 2002;62:103-11.
10. Ahmad F, Aletti P, Charra-Brunaud C, Van der Laarse R, Lapeyre M, Hoffstetter S, et al. Influence of dose point and inverse optimization on interstitial cervical and oropharyngeal carcinoma brachytherapy. Radiother Oncol 2004;73:331-7.
11. Tanderup K, Hellebust TP, Honore HB, Nielsen SK, Olsen DR, Grau C, et al. Dose optimisation in single plane interstitial brachytherapy. Radiother Oncol 2006;81:105-11.
12. Vikram B, Deore S, Beitler JJ, Sood B, Mullokandov E, Kapulsky A, et al. The relationship between dose heterogeneity ("hot" spots) and complications following high-dose rate brachytherapy. Int J Radiat Oncol Biol Phys 1999;43:983-7.
13. Wazer DE, Lowther D, Boyle T, Ulin K, Neuschatz A, Ruthazer R, et al. Clinically evident fat necrosis in women treated with high-dose-rate brachytherapy alone for early-stage breast cancer. Int J Radiat Oncol Biol Phys 2001;50:107-11.